CH:MED's free cash flow for Q2 2025 was CHF0.80. For the 2025 fiscal year, CH:MED's free cash flow was decreased by CHF and operating cash flow was CHF0.07. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	5.31	3.08	3.49	5.06	6.28
Quick Ratio	3.57	1.59	1.72	3.49	4.35
Cash Ratio	2.42	0.55	0.52	2.38	3.22
Solvency Ratio	0.11	0.15	0.14	0.31	0.21
Operating Cash Flow Ratio	0.55	0.43	-0.10	0.60	0.49
Short-Term Operating Cash Flow Coverage	0.00	43.21	-8.52	-19.74	-10.48
Net Current Asset Value	CHF 60.27M	CHF 46.84M	CHF 47.77M	CHF 101.30M	CHF 91.35M
Leverage Ratios
Debt-to-Assets Ratio	0.27	0.08	0.16	0.08	0.10
Debt-to-Equity Ratio	0.47	0.11	0.22	0.11	0.13
Debt-to-Capital Ratio	0.32	0.10	0.18	0.10	0.11
Long-Term Debt-to-Capital Ratio	0.31	0.00	<0.01	0.00	<0.01
Financial Leverage Ratio	1.78	1.37	1.38	1.33	1.33
Debt Service Coverage Ratio	3.99	10.74	3.46	60.44	97.12
Interest Coverage Ratio	0.98	5.27	-0.40	7.50	2.26
Debt to Market Cap	0.12	<0.01	<0.01	>-0.01	>-0.01
Interest Debt Per Share	10.98	2.34	4.79	2.16	2.43
Net Debt to EBITDA	0.10	0.07	1.94	-2.24	-3.98
Profitability Margins
Gross Profit Margin	79.11%	79.04%	74.05%	76.04%	73.55%
EBIT Margin	5.17%	5.40%	-1.35%	5.66%	-1.51%
EBITDA Margin	14.97%	11.65%	8.88%	16.33%	10.94%
Operating Profit Margin	3.65%	4.29%	-1.02%	6.89%	2.43%
Pretax Profit Margin	-0.06%	0.85%	-3.88%	5.16%	-2.58%
Net Profit Margin	-0.21%	0.29%	-3.16%	4.28%	-0.74%
Continuous Operations Profit Margin	-0.16%	0.29%	-3.16%	4.28%	-0.74%
Net Income Per EBT	347.86%	34.50%	81.52%	82.91%	28.62%
EBT Per EBIT	-1.62%	19.71%	379.25%	74.88%	-106.36%
Return on Assets (ROA)	-0.10%	0.18%	-1.76%	2.29%	-0.33%
Return on Equity (ROE)	-0.18%	0.24%	-2.43%	3.05%	-0.44%
Return on Capital Employed (ROCE)	2.07%	3.00%	-0.65%	4.18%	1.21%
Return on Invested Capital (ROIC)	5.60%	1.01%	-0.51%	3.40%	0.35%
Return on Tangible Assets	-0.12%	0.22%	-2.64%	2.41%	-0.35%
Earnings Yield	-0.05%	0.06%	-0.60%	0.45%	-0.17%
Efficiency Ratios
Receivables Turnover	5.13	4.62	4.07	4.39	4.63
Payables Turnover	5.55	5.39	4.94	4.65	5.89
Inventory Turnover	0.57	0.65	0.68	0.71	0.68
Fixed Asset Turnover	3.03	2.65	2.31	2.48	1.84
Asset Turnover	0.51	0.61	0.56	0.54	0.45
Working Capital Turnover Ratio	1.10	2.19	1.53	1.16	0.89
Cash Conversion Cycle	647.37	572.42	553.83	521.96	552.75
Days of Sales Outstanding	71.19	79.05	89.77	83.05	78.90
Days of Inventory Outstanding	641.96	561.05	537.88	517.42	535.84
Days of Payables Outstanding	65.78	67.69	73.83	78.50	61.98
Operating Cycle	713.16	640.11	627.66	600.47	614.74
Cash Flow Ratios
Operating Cash Flow Per Share	2.28	1.63	-0.33	1.78	1.07
Free Cash Flow Per Share	1.61	0.10	-1.92	0.90	-0.04
CapEx Per Share	0.66	1.54	1.59	0.88	1.11
Free Cash Flow to Operating Cash Flow	0.71	0.06	5.79	0.50	-0.04
Dividend Paid and CapEx Coverage Ratio	3.43	1.06	-0.21	2.02	0.97
Capital Expenditure Coverage Ratio	3.43	1.06	-0.21	2.02	0.97
Operating Cash Flow Coverage Ratio	0.22	0.74	-0.08	0.87	0.46
Operating Cash Flow to Sales Ratio	0.12	0.09	-0.02	0.13	0.10
Free Cash Flow Yield	2.05%	0.11%	-2.34%	0.69%	-0.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-1.90K	1.66K	-167.81	224.70	-579.99
Price-to-Sales (P/S) Ratio	4.02	4.85	5.31	9.61	4.29
Price-to-Book (P/B) Ratio	3.54	4.03	4.08	6.86	2.57
Price-to-Free Cash Flow (P/FCF) Ratio	48.79	876.69	-42.71	145.42	-1.20K
Price-to-Operating Cash Flow Ratio	33.62	51.47	-247.09	73.33	43.40
Price-to-Earnings Growth (PEG) Ratio	16.41	-15.05	0.91	-0.27	4.01
Price-to-Fair Value	3.54	4.03	4.08	6.86	2.57
Enterprise Value Multiple	26.95	41.68	61.69	56.62	35.21
Enterprise Value	953.38M	1.03B	1.00B	1.48B	491.70M
EV to EBITDA	26.95	41.68	61.69	56.62	35.21
EV to Sales	4.03	4.85	5.48	9.24	3.85
EV to Free Cash Flow	48.96	878.16	-44.09	139.87	-1.08K
EV to Operating Cash Flow	34.68	51.56	-255.09	70.53	38.99
Tangible Book Value Per Share	16.87	15.56	10.92	17.76	16.91
Shareholders’ Equity Per Share	21.62	20.84	20.09	18.98	18.10
Tax and Other Ratios
Effective Tax Rate	-1.75	0.65	0.19	0.18	0.70
Revenue Per Share	19.56	17.33	15.45	13.55	10.85
Net Income Per Share	-0.04	0.05	-0.49	0.58	-0.08
Tax Burden	3.48	0.35	0.82	0.83	0.29
Interest Burden	-0.01	0.16	2.87	0.91	1.71
Research & Development to Revenue	0.15	0.12	0.13	0.11	0.11
SG&A to Revenue	0.16	0.16	0.16	0.16	0.17
Stock-Based Compensation to Revenue	<0.01	<0.01	0.01	0.01	0.02
Income Quality	-56.45	32.25	0.68	3.06	-13.37

Currency in CHF

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing